Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
about
Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractDoes outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesisAngiotensin II-related hypertension and eye diseases.Evaluation of (131)I-anti-angiotensin II type 1 receptor monoclonal antibody as a reporter for hepatocellular carcinoma.Angiogenesis: a harmonized target for recovery after stroke.Gene variants in the angiogenesis pathway and prostate cancer.Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancerAT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.Angiotensin receptor blockade has protective effects on the poststenotic porcine kidney.Role of Jagged1-Hey1 Signal in Angiotensin II-induced Impairment of Myocardial AngiogenesisCritical review of cancer risk associated with angiotensin receptor blocker therapy.Cardiovascular medications in angiogenesis--how to avoid the sting in the tail.Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Angiotensin-(1-7): beyond its central effects on blood pressure.Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).Vascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure.Frictional purpuric eruption associated with angiotensin II receptor blockers.Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?[Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor].Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancerDo anti-hypertensive renin-angiotensin system inhibitors contribute to the development of classical Kaposi sarcoma?
P2860
Q27009109-1D3F4244-8AFE-4441-B69E-0F49B90B625BQ30576331-E1B13CA5-A7DC-412E-8AB6-FB1108F54CF3Q33603639-BFDDF275-B7E1-4FF9-B0C7-C2CF1BF75234Q34125083-8944D1CD-1812-4B73-99C0-68C2B12970C1Q34251889-506CCFA8-12F0-4AF6-9084-1AFEE451694FQ35084992-95C7203A-CEC5-4469-8ECE-1CF963E01AB0Q36113683-3CD4B626-0E34-4251-9F73-4802860FE530Q36118876-63EBBB1B-58AD-42FE-A1BC-51CE83E5D517Q36250185-F0990C7B-BB56-4FA9-B4F1-226BD9E38347Q36573232-50F9584D-DE36-4F5B-8578-61947E660A0CQ37067357-DAABE916-3A0C-4DD9-8596-3879B34D44ABQ37640961-5DBE14F4-2647-4D53-9B79-D6B9EAA35AE0Q37975493-B3D2A8DD-27D6-4EA6-A13F-22A3160323F8Q38001305-7049B017-18C3-4D4E-A611-C035E5FF28C6Q38130312-AE8C0D36-4FEB-4A82-AC7E-B4749FB8DBBAQ38569323-77BE52F0-0C53-4A07-B7C9-4DA1BA874F67Q38950984-E4A3B6C6-92C9-48C4-9783-B6B45F6C95EEQ39134052-907E8852-F5F2-43E0-A22C-F22C7FAB7F82Q41819842-F77A9463-FDCD-4058-8EE6-5E243ED1A581Q42739089-AF0515BC-D482-4C7F-AB21-E4E85BD0331CQ42837025-E676CAC2-CF79-4439-ABE2-9278E79B9E19Q44551243-6621DC32-C377-4700-8EAC-068745C16822Q47626689-33345907-A854-4775-AC6C-631A826AC8ECQ52632539-7671C3BF-41F0-41F9-8604-D48CF5455FC5Q54349072-4CE34EC2-0F4F-42CA-95CC-D86F820CBC8BQ55481367-1B3741A3-D8C6-4CCF-9736-67D13780B104Q57169593-5A52B4A2-8337-488B-806C-353ADEF3A687Q57286237-D1A9C750-9F4D-457E-9990-C9E77A60DA13
P2860
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@en
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@nl
type
label
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@en
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@nl
prefLabel
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@en
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.
@nl
P2093
P2860
P356
P1433
P1476
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence
@en
P2093
David L Deremer
Lauren M Willis
Payaningal R Somanath
Susan C Fagan
P2860
P304
P356
10.1042/CS20100389
P407
P577
2011-04-01T00:00:00Z